Related Experiment Videos

Statin use and survival outcomes in elderly patients with heart failure

Joel G Ray1, Yanyan Gong, Kathy Sykora

  • 1Department of Medicine, St Michaels Hospital, University of Toronto, Ontario M5B 1W8, Canada. rayj@smh.toronto.on.ca

Archives of Internal Medicine
|January 12, 2005
PubMed

Insights

Statin use in seniors with newly diagnosed heart failure was linked to a reduced risk of death. This study suggests statins may improve survival for older adults with congestive heart failure.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Coronary artery disease is a primary cause of heart failure.
  • Statins are proven for coronary heart disease prevention but their role in heart failure patients was unclear.

Purpose of the Study:

  • To investigate the association between statin use and outcomes in elderly patients recently diagnosed with heart failure.

Main Methods:

  • A population-based retrospective cohort study in Ontario, Canada.
  • Included individuals aged 66-85, cancer-free, surviving 90 days post-heart failure diagnosis.
  • Compared outcomes (all-cause mortality, myocardial infarction, stroke) between statin users (n=1,146) and non-users (n=27,682).

Main Results:

  • Statin use was associated with a significantly lower risk of death, myocardial infarction, or stroke (adjusted HR, 0.72; 95% CI, 0.63-0.83).
  • The primary benefit was a reduction in all-cause mortality (adjusted HR, 0.67; 95% CI, 0.57-0.78).
  • No significant reduction was observed for subsequent myocardial infarction or stroke.

Conclusions:

  • Statin use is linked to decreased mortality in seniors with new-onset congestive heart failure.
  • Limitations include inability to control for all prognostic factors like ejection fraction and lipid levels.
  • Further research is needed to identify specific heart failure patient subgroups who may benefit most from statins.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...